Decatur Capital Management Inc. Makes New Investment in CME Group Inc. $CME

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Decatur Capital Management Inc. acquired a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 12,273 shares of the financial services provider's stock, valued at approximately $3,256,000. CME Group makes up 1.7% of Decatur Capital Management Inc.'s holdings, making the stock its 18th biggest holding.

Other institutional investors have also recently added to or reduced their stakes in the company. Wayfinding Financial LLC purchased a new position in CME Group during the first quarter worth approximately $25,000. Cornerstone Planning Group LLC lifted its position in CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after buying an additional 55 shares in the last quarter. Golden State Wealth Management LLC lifted its position in CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after buying an additional 98 shares in the last quarter. Alpine Bank Wealth Management purchased a new position in CME Group during the first quarter worth approximately $32,000. Finally, Financial Gravity Asset Management Inc. purchased a new position in CME Group during the first quarter worth approximately $32,000. Hedge funds and other institutional investors own 87.75% of the company's stock.

Analyst Ratings Changes

A number of brokerages recently commented on CME. Erste Group Bank downgraded CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Wall Street Zen cut CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Oppenheimer raised their target price on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research note on Thursday, July 24th. UBS Group reissued a "neutral" rating and set a $305.00 target price on shares of CME Group in a research note on Thursday, July 24th. Finally, Barclays set a $298.00 target price on CME Group and gave the stock an "equal weight" rating in a research note on Thursday, July 24th. Four analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $261.93.

CME Group Trading Down 1.4%

Shares of NASDAQ CME traded down $3.80 during trading on Friday, reaching $269.52. The stock had a trading volume of 1,591,589 shares, compared to its average volume of 1,923,555. CME Group Inc. has a fifty-two week low of $206.44 and a fifty-two week high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The business's 50-day moving average price is $275.82 and its 200-day moving average price is $268.31. The company has a market cap of $97.13 billion, a P/E ratio of 26.09, a PEG ratio of 4.95 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. During the same period in the previous year, the firm posted $2.56 EPS. CME Group's revenue for the quarter was up 10.4% on a year-over-year basis. On average, equities research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's payout ratio is presently 48.40%.

Insider Buying and Selling at CME Group

In related news, Director William R. Shepard bought 256 shares of the stock in a transaction that occurred on Wednesday, June 25th. The stock was purchased at an average cost of $270.53 per share, with a total value of $69,255.68. Following the purchase, the director directly owned 258,196 shares of the company's stock, valued at $69,849,763.88. This trade represents a 0.10% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Charles P. Carey sold 500 shares of the business's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the transaction, the director directly owned 4,900 shares of the company's stock, valued at $1,300,215. The trade was a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.30% of the company's stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.